National medical insurance has reduced patients’ financial burden by more than 500 billion yuan, and the average price of drugs procured through national centralized purchasing has fallen by over 50%.
On May 18, the State Council Information Office held a series of thematic press conferences under the “Authoritative Departments Discuss the Start” initiative. A spokesperson from the National Healthcare Security Administration stated that since its establishment in 2018, the Administration has been committed to promoting high-quality development of the national medical insurance system.
Over the past five years, the National Healthcare Security Administration has worked to include a large number of exclusive‑brand anticancer and rare‑disease drugs in the national medical insurance scheme at affordable prices, resulting in cumulative cost reductions of more than 500 billion yuan for patients after reimbursement. Nationally organized centralized procurement has driven average price cuts of over 50% for 333 drug products, and average price reductions of more than 80% for eight high‑value medical consumables, including cardiac stents and artificial joints; when combined with local‑alliance procurement, these measures have collectively eased the financial burden by approximately 500 billion yuan. Outpatient medications for hypertension and diabetes have been incorporated into the basic medical insurance coverage for residents, benefiting 140 million people with chronic conditions. The scale of direct settlement for out-of‑province medical care has grown from 1.318 million visits in 2018 to 38.1235 million visits in 2022, an increase of 28 times. Meanwhile, the pilot program for long-term care insurance has continued to expand, now covering 49 cities and 169 million people, providing support to 1.95 million individuals with disabilities.
Hu Jinglin, Director of the National Healthcare Security Administration, stated: Over the past five years, we have strengthened and expanded the world’s largest basic medical insurance network. The annual total revenue of the basic medical insurance fund (including maternity insurance) has grown from RMB 2.14 trillion to RMB 3.09 trillion, while annual total expenditures have increased from RMB 1.78 trillion to RMB 2.46 trillion. The fund has operated steadily, with a surplus in recent years. The government’s per capita annual subsidy for residents’ premium contributions has risen from RMB 490 to RMB 610. In 2022 alone, the total amount of fiscal subsidies reached RMB 600 billion.
Service Hotline: 0571-64257850
Email:hzsuode@163.com
Address: No. 7 Yaolin Road, Tonglu County, Hangzhou City, Zhejiang Province
Powered by:
Patient-centered and clinically driven
Integration of research and medicine for mutual advancement
Service Hotline: 0571-64257850
Email:hzsuode@163.com
Address: No. 7 Yaolin Road, Tonglu County, Hangzhou City, Zhejiang Province
Follow Suode Medical
Powered by: